| dc.contributor.author | Radulovic, Maja | |
| dc.contributor.author | Stenmark, Harald Alfred | |
| dc.date.accessioned | 2021-09-27T11:50:42Z | |
| dc.date.available | 2021-09-27T11:50:42Z | |
| dc.date.created | 2021-02-05T15:58:51Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | EMBO Journal. 2020, 39 (18), 1-3. | en_US |
| dc.identifier.issn | 0261-4189 | |
| dc.identifier.uri | https://hdl.handle.net/11250/2783731 | |
| dc.description.abstract | Mutations in several genes encoding for lysosomal proteins are involved in Parkinson's disease (PD). In this issue, Herbst et al (2020) show that PD-related leucine-rich repeat kinase 2 (LRRK2) is activated in response to pathogen or membranolytic drug-induced damage of phagolysosomes and lysosomes in macrophages, and regulates endolysosomal homeostasis by controlling the balance between membrane repair and degradation. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | EMBO Press | en_US |
| dc.title | LRRK2 to the rescue of damaged endomembranes | en_US |
| dc.type | Peer reviewed | en_US |
| dc.type | Journal article | en_US |
| dc.description.version | acceptedVersion | en_US |
| dc.rights.holder | This is the authors' accepted manuscript to an article published by EMBO Press. | en_US |
| dc.source.pagenumber | 1-3 | en_US |
| dc.source.volume | 39 | en_US |
| dc.source.journal | EMBO Journal | en_US |
| dc.source.issue | 18 | en_US |
| dc.identifier.doi | 10.15252/embj.2020106162 | |
| dc.identifier.cristin | 1887181 | |
| dc.relation.project | Norges forskningsråd: 223255 | en_US |
| cristin.ispublished | true | |
| cristin.fulltext | original | |
| cristin.fulltext | postprint | |
| cristin.qualitycode | 2 | |
